Analytic for Hemodynamic Instability (AHI) vs Study Watch with Irregular Pulse Monitor

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
Analytic for Hemodynamic Instability (AHI)
by Fifth Eye
VS
Study Watch with Irregular Pulse Monitor
by Verily Life Sciences

AI Verdict

Tool A, Fifth Eye's AHI System, is designed for continuous in-hospital monitoring of adult patients to predict hemodynamic instability hours before traditional vital signs. Tool B, Verily's Study Watch with Irregular Pulse Monitor, is a prescription-only wearable for adult patients (22+) to monitor and record single-channel ECG rhythms and detect irregular pulses indicative of atrial fibrillation, primarily for clinical research and professional healthcare settings. While both utilize ECG data and AI for cardiac monitoring, their deployment, target conditions, and primary use cases (proactive instability prediction in-hospital vs. irregular pulse detection via a wearable for AFib) make them adjacent rather than direct competitors.

Choose Analytic for Hemodynamic Instability (AHI) if…

Choose Fifth Eye's AHI System if you need continuous, real-time AI-driven monitoring for adult in-hospital patients to predict hemodynamic instability hours before traditional vital signs. This tool is ideal for critical care settings, emergency departments, and telemetry units to proactively identify patient deterioration, reduce nurse burden, and optimize resource allocation.

View Analytic for Hemodynamic Instability (AHI) →

Choose Study Watch with Irregular Pulse Monitor if…

Choose Verily's Study Watch with Irregular Pulse Monitor if you are conducting clinical research or managing adult out-of-hospital patients (22+) susceptible to atrial fibrillation, requiring continuous, prescription-only, wrist-worn ECG monitoring. This device is best suited for detecting irregular pulses, recording single-channel ECG rhythms, and supporting long-term data capture in a research or remote healthcare setting.

View Study Watch with Irregular Pulse Monitor →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Analytic for Hemodynamic Instability (AHI) Study Watch with Irregular Pulse Monitor
Pricing Contact vendor Contact for pricing
Deployment Software as a Medical Device (SaMD) integrated into in-hospital monitoring platforms; accessible via any browser-enabled device. Device-based (wrist-worn watch)
FDA Status 1 AI-estimated True AI-estimated
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Analytic for Hemodynamic Instability (AHI)

Tool A (AHI System) is designed for seamless integration into existing in-hospital monitoring platforms and provides easy-to-interpret visual indicators (red, yellow, green), reducing nurse surveillance burden and streamlining workflow. Tool B (Study Watch) is a wearable device that requires patients to take a 60-second ECG measurement upon irregular pulse detection, and while it has an easy-to-use interface, it is primarily for clinical research and professional healthcare settings, with patients not having direct access to the collected waveform.

Clinical Value

Analytic for Hemodynamic Instability (AHI)

Tool A (AHI System) provides early warnings of hemodynamic instability hours ahead of traditional vital signs, with studies showing it can predict events up to 26 hours in advance and identify risk in 93% of rapid response team events. Tool B (Study Watch) accurately detects irregular pulses indicative of atrial fibrillation and has been validated for sleep monitoring and Parkinson's disease research, but its primary focus is on data collection for clinical research rather than immediate clinical decision support for a broad range of critical conditions.

Pricing & Value

Tie

Both tools require contacting the vendor for pricing details, making a direct comparison of cost-effectiveness difficult. While Tool A aims to reduce costs by preventing adverse events and optimizing resource allocation, and Tool B focuses on accelerating clinical research, neither provides transparent pricing information to assess overall value.

Enterprise Readiness

Analytic for Hemodynamic Instability (AHI)

Tool A (AHI System) is designed for integration into existing in-hospital monitoring platforms like Sickbay and VitalConnect, indicating strong enterprise readiness for hospital environments. Tool B (Study Watch) is a prescription-only device primarily for clinical research and healthcare facility use, and while it integrates with Verily's precision health platform, its enterprise readiness is more geared towards research studies rather than broad hospital-wide deployment for continuous patient monitoring.

Innovation

Analytic for Hemodynamic Instability (AHI)

Tool A (AHI System) offers a unique and innovative approach by continuously predicting hemodynamic instability using only ECG lead II data, providing early warnings significantly ahead of traditional vital signs. Tool B (Study Watch) is innovative in its application as a clinical-grade wearable for research, collecting diverse biometric data, but its core function of ECG recording and irregular pulse detection is a more established application of wearable technology.

Support & Docs

Tie

Both tools are FDA-cleared, implying a level of regulatory documentation and support. However, specific details regarding ongoing customer support, training programs, or publicly available comprehensive documentation beyond product descriptions and clinical studies are not readily available for either tool.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Analytic for Hemodynamic Instability (AHI) Study Watch with Irregular Pulse Monitor
Name Analytic for Hemodynamic Instability (AHI) Study Watch with Irregular Pulse Monitor
Company Fifth Eye Verily Life Sciences
Description FDA-cleared, AI-driven clinical decision support software that continuously monitors adult in-hospital patients for signs of hemodynamic instability, providing early warnings hours ahead of traditional vital signs. FDA-cleared, prescription-only wearable device designed for adult patients (22+) to monitor and record single-channel ECG rhythms and detect irregular pulses indicative of atrial fibrillation, primarily for use in clinical research and professional healthcare settings.
Key Monitoring Capability Predicts hemodynamic instability earlier than vital signs (up to 26 hours for AHI-PI) using continuous ECG lead II data. Single-channel ECG recording and irregular pulse monitoring and notification (e.g., for Atrial Fibrillation).
Target User/Setting Adult in-hospital patients; clinical decision support for healthcare professionals. Adult patients (22+) for clinical research and professional healthcare settings.

Videos

Demos, reviews, and walkthroughs featuring Analytic for Hemodynamic Instability (AHI) and Study Watch with Irregular Pulse Monitor.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Fifth Eye's AHI System integrates with in-hospital monitoring platforms like Sickbay and VitalConnect, aiming to simplify deployment and use by eliminating the need for additional hardware or user interfaces. It provides real-time clinical analytics based on continuous ECG lead II data, offering easy-to-interpret visual indicators (red, yellow, green) to streamline workflow and potentially reduce nurse surveillance burden. The system is designed to provide adjunctive information to support clinical decision-making, with a recommended action of increased vigilance when an 'AHI Unstable' window is indicated. The learning curve should be minimal as it integrates into existing platforms and provides intuitive visual cues.
Fifth Eye's AHI System is designed to predict hemodynamic instability earlier than traditional vital signs, with studies showing it can provide warnings hours ahead, and up to 26 hours for AHI-PI before a Rapid Response Team event. In an FDA-reviewed study, AHI identified hemodynamic instability with 96% sensitivity and stable patients with 85% specificity, correlating highly with hemodynamic instability defined as hypotension plus tachycardia. It continuously analyzes ECG lead II data to detect subtle physiologic changes that may go undetected by vital signs alone.
The Verily Study Watch is a prescription-only wearable device primarily designed for use in clinical research and professional healthcare settings to monitor and record single-channel ECG rhythms and detect irregular pulses indicative of atrial fibrillation. While it can provide continuous data capture, the workflow involves the device prompting a user to take a single-lead ECG upon irregular pulse detection, with results then reviewed by a cardiographic technician before being reported to the physician. This suggests a workflow more aligned with data collection for research or targeted diagnostic confirmation rather than continuous, real-time clinical decision support at the bedside.
The Verily Study Watch with Irregular Pulse Monitor has demonstrated high accuracy in identifying atrial fibrillation (AFib). A study showed interval-level sensitivity of 96.1% and specificity of 98.1% for AF detection, with photoplethysmography-derived AF burden estimation highly correlated with reference devices. Another study on the Zio Watch (which utilizes Verily's technology) reported interval-level sensitivity of 93.6% and specificity of 99.1% for AFib detection. The device is intended to record, store, transfer, and display single-channel ECG rhythms, and can recommend ECG acquisition upon irregular pulse detection.
For Tool A (AHI), its integration with existing in-hospital monitoring platforms like Sickbay suggests a more streamlined multi-site rollout within facilities already using those platforms, potentially simplifying data integration. Fifth Eye's machine-learning technology is licensed from the University of Michigan, and the company focuses on providing real-time clinical analytics. For Tool B (Study Watch), its primary use in clinical research and investigational settings, along with its device-based deployment, implies that multi-site rollout would likely involve managing individual device distribution, patient education, and data collection protocols across sites. Verily has collaborations to integrate wearable sensor data with medical records and other patient data sources for research, which could be a factor in multi-site research studies.
For Tool A (AHI), security recommendations include using a Virtual Private Network (VPN) for remote access, regularly installing operating system updates, and running anti-virus software. Users are also advised to use strong, regularly rotated passwords. For Tool B (Study Watch), all data stored on the watch are encrypted before being uploaded and processed in the cloud using Verily's backend algorithms and machine learning tools. Verily's broader precision health platform, Pre, is designed to allow researchers to exchange, govern, and analyze biomedical data, and has a FHIR-native approach for data integration.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Analytic for Hemodynamic Instability (AHI) or Study Watch with Irregular Pulse Monitor

Backers

Who funded each tool's parent company.

Study Watch with Irregular Pulse Monitor

AI Tool Finder
AI-powered search. Results may not be comprehensive.